Have a personal or library account? Click to login
Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab Cover

Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab

Open Access
|Mar 2026

Authors

Peter Popovic

peter.popovic@kclj.si

Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Ana Kalamutova

Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia

Mihajlo Djokic

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia

Anka Cuderman

Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

Gasper Boltezar

Diagnostic Center Bled Group, Bled, Slovenia

Blaz Trotovsek

Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Abdominal Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2026-0015 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 40 - 48
Submitted on: Nov 27, 2025
|
Accepted on: Feb 4, 2026
|
Published on: Mar 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Peter Popovic, Ana Kalamutova, Mihajlo Djokic, Anka Cuderman, Gasper Boltezar, Blaz Trotovsek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.